-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?
Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?
STAAR Surgical Company (NASDAQ:STAA), might not be a large cap stock, but it saw a significant share price rise of over 20% in the past couple of months on the NASDAQGM. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, could the stock still be trading at a relatively cheap price? Let's examine STAAR Surgical's valuation and outlook in more detail to determine if there's still a bargain opportunity.
Check out our latest analysis for STAAR Surgical
What's The Opportunity In STAAR Surgical?
The stock is currently trading at US$98.49 on the share market, which means it is overvalued by 27% compared to my intrinsic value of $77.30. This means that the opportunity to buy STAAR Surgical at a good price has disappeared! If you like the stock, you may want to keep an eye out for a potential price decline in the future. Since STAAR Surgical's share price is quite volatile, this could mean it can sink lower (or rise even further) in the future, giving us another chance to invest. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.
What kind of growth will STAAR Surgical generate?
NasdaqGM:STAA Earnings and Revenue Growth August 28th 2022Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. STAAR Surgical's earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.
What This Means For You
Are you a shareholder? STAA's optimistic future growth appears to have been factored into the current share price, with shares trading above its fair value. At this current price, shareholders may be asking a different question – should I sell? If you believe STAA should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.
Are you a potential investor? If you've been keeping tabs on STAA for some time, now may not be the best time to enter into the stock. The price has surpassed its true value, which means there's no upside from mispricing. However, the positive outlook is encouraging for STAA, which means it's worth diving deeper into other factors in order to take advantage of the next price drop.
So while earnings quality is important, it's equally important to consider the risks facing STAAR Surgical at this point in time. You'd be interested to know, that we found 1 warning sign for STAAR Surgical and you'll want to know about this.
If you are no longer interested in STAAR Surgical, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
纳斯达克(STAAR Surgical Company)可能不是一只大盘股,但它在纳斯达克的股价在过去几个月里大幅上涨了20%以上。由于许多分析师都在关注这只中型股,我们可能会预计,任何对价格敏感的声明都已经计入了该股的股价。然而,该股目前的交易价格还会相对便宜吗?让我们更详细地研究STAAR Surgical的估值和前景,以确定是否仍有逢低买入的机会。
查看我们对STAAR Surggical的最新分析
STAAR Surgical有什么机会?
该股目前在股票市场上的交易价格为98.49美元,这意味着与我77.30美元的内在价值相比,它的估值被高估了27%。这意味着,以好价格收购STAAR Surgical的机会消失了!如果你喜欢这只股票,你可能想要密切关注未来可能的价格下跌。由于STAAR Surgical的股价波动很大,这可能意味着它未来可能会下跌(或进一步上涨),给我们另一个投资机会。这是基于其较高的贝塔系数,这是衡量该股相对于市场其他股票波动程度的一个很好的指标。
STAAR Surgical将带来怎样的增长?
NasdaqGM:Staa收益和收入增长2022年8月28日当你考虑购买一只股票时,未来前景是一个重要的方面,特别是如果你是一个寻求投资组合增长的投资者。尽管价值投资者会争辩说,相对于价格的内在价值才是最重要的,但一个更有说服力的投资命题是以低廉的价格实现高增长潜力。未来几年,STAAR Surgical的收益预计将翻一番,这表明未来非常乐观。这应该会带来更强劲的现金流,从而推动更高的股价。
这对你意味着什么
你是股东吗?Staa乐观的未来增长似乎已被计入目前的股价,股价高于其公允价值。在目前的价格下,股东们可能会问一个不同的问题--我应该卖出吗?如果你认为STAA的交易价格应该低于当前价格,那么高价抛售,并在价格跌至接近实际价值时再次买入,可能是有利可图的。但在你做出这个决定之前,先看看它的基本面是否发生了变化。
你是潜在的投资者吗?如果你关注STAA已经有一段时间了,现在可能不是买入该股的最佳时机。价格已经超过了它的真实价值,这意味着错误定价不会带来任何好处。然而,积极的前景对STAA来说是令人鼓舞的,这意味着为了利用下一次价格下跌,值得更深入地研究其他因素。
因此,尽管收益质量很重要,但考虑到STAAR Surgical目前面临的风险也同样重要。你会有兴趣知道的,我们发现1个STAAR外科警示标志你会想知道这一点的。
如果您对STAAR Surgical不再感兴趣,您可以使用我们的免费平台查看我们列出的50多只具有高增长潜力的其他股票。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧